Identification | Back Directory | [Name]
3-Pyridinecarboxamide, N-[3-[(1S)-1-[[6-(3,4-dimethoxyphenyl)-2-pyrazinyl]amino]ethyl]phenyl]-5-methyl- | [CAS]
1619931-27-9 | [Synonyms]
GB002 PK-10571 Seralutinib Seralutinib (GB002) Seralutinib (PK-10571 (S)-N-(3-(1-((6-(3,4-Dimethoxyphenyl)pyrazin-2-yl)amino)ethyl)phenyl)-5-methylnicotinamide 3-Pyridinecarboxamide, N-[3-[(1S)-1-[[6-(3,4-dimethoxyphenyl)-2-pyrazinyl]amino]ethyl]phenyl]-5-methyl- PK 10571,Seralutinib,inhibit,arterial,PDGFR,PK10571,PK-10571,PAH,Pulmonary,hypertension,GB 002,GB-002,Inhibitor,Platelet-derived growth factor receptor | [Molecular Formula]
C27H27N5O3 | [MDL Number]
MFCD28502207 | [MOL File]
1619931-27-9.mol | [Molecular Weight]
469.54 |
Chemical Properties | Back Directory | [Boiling point ]
601.4±55.0 °C(Predicted) | [density ]
1.252±0.06 g/cm3(Predicted) | [storage temp. ]
Store at -20°C | [solubility ]
DMSO : 100 mg/mL (212.98 mM; Need ultrasonic) | [form ]
Solid | [pka]
12.16±0.70(Predicted) | [color ]
White to light yellow |
|
Company Name: |
ChemCell Biomedicine Co.,Ltd.
|
Tel: |
020-13556033878 2965585218 13556033878 |
Website: |
http://m.is0513.com/ShowSupplierProductsList15061/0.htm |
|